AR062715A1 - Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico - Google Patents
Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoicoInfo
- Publication number
- AR062715A1 AR062715A1 ARP070103975A ARP070103975A AR062715A1 AR 062715 A1 AR062715 A1 AR 062715A1 AR P070103975 A ARP070103975 A AR P070103975A AR P070103975 A ARP070103975 A AR P070103975A AR 062715 A1 AR062715 A1 AR 062715A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- formula
- unsubstituted
- compound
- benzoico
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicacion 5: Un proceso para preparar un compuesto de la formula (1) o una sal farmacéuticamente aceptable de éste, caracterizado porque: R1 es un alquilo sustituido o no sustituido, un cicloalquilo sustituido o no sustituido, un heterocicloalquilo sustituido o no sustituido, un arilo sustituido o no sustituido, un heteroarilo sustituido o no sustituido, -(CH2CH2O)nR6 o cualquier grupo biohidrolizable; X es en cada caso independientemente F, CI, Br o I; y m es un numero entero de 1 a 5, que comprende realizar las siguientes etapas en el mismo solvente: (1) hacer reaccionar el éster de ácido cianobenzoico de (formula 2) con hidroxilamina, para producir el compuesto de formula (3), seguido por (2) acilacion con un cloruro de halobenzoilo, para producir: el compuesto de formula (4) seguido por (3) condensacion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84359506P | 2006-09-08 | 2006-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR062715A1 true AR062715A1 (es) | 2008-11-26 |
Family
ID=38935880
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070103975A AR062715A1 (es) | 2006-09-08 | 2007-09-07 | Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico |
| ARP170100223A AR107474A2 (es) | 2006-09-08 | 2017-01-27 | Proceso para la preparación de un ácido de 1,2,4-oxadiazol benzoico |
| ARP200101362A AR118922A2 (es) | 2006-09-08 | 2020-05-12 | Procesos para la preparación de ácidos de 1,2,4-oxadiazol benzoico |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170100223A AR107474A2 (es) | 2006-09-08 | 2017-01-27 | Proceso para la preparación de un ácido de 1,2,4-oxadiazol benzoico |
| ARP200101362A AR118922A2 (es) | 2006-09-08 | 2020-05-12 | Procesos para la preparación de ácidos de 1,2,4-oxadiazol benzoico |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7678922B2 (es) |
| EP (1) | EP2059513B1 (es) |
| JP (2) | JP5955494B2 (es) |
| KR (1) | KR101466368B1 (es) |
| CN (1) | CN101535284B (es) |
| AR (3) | AR062715A1 (es) |
| AU (1) | AU2007292915B2 (es) |
| BR (1) | BRPI0716996B8 (es) |
| CA (2) | CA2842625C (es) |
| CL (1) | CL2007002606A1 (es) |
| DK (1) | DK2059513T3 (es) |
| ES (1) | ES2404348T3 (es) |
| HK (1) | HK1134094A1 (es) |
| IL (1) | IL197445A (es) |
| MX (1) | MX2009002439A (es) |
| MY (1) | MY148598A (es) |
| NZ (2) | NZ575511A (es) |
| PE (2) | PE20120669A1 (es) |
| PL (1) | PL2059513T3 (es) |
| PT (1) | PT2059513E (es) |
| RU (1) | RU2495030C2 (es) |
| TW (1) | TWI482761B (es) |
| UA (1) | UA99265C2 (es) |
| WO (1) | WO2008030570A1 (es) |
| ZA (1) | ZA200901782B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2926542T3 (es) | 2003-04-11 | 2022-10-26 | Ptc Therapeutics Inc | Compuestos de ácido 1,2,4-oxadiazol benzoico y su uso para supresión de mutaciones finalizadoras y el tratamiento de enfermedades |
| CA2603402C (en) | 2005-04-08 | 2017-10-31 | Ptc Therapeutics, Inc. | Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| SG170819A1 (en) | 2006-03-30 | 2011-05-30 | Ptc Therapeutics Inc | Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith |
| RU2495030C2 (ru) * | 2006-09-08 | 2013-10-10 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы получения 1,2,4-оксадиазолбензойных кислот |
| WO2008130370A1 (en) | 2006-09-25 | 2008-10-30 | Ptc Therapeutics, Inc. | Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression |
| MX2009003160A (es) | 2006-09-25 | 2009-04-06 | Ptc Therapeutics Inc | Formas cristalinas del acido 3-[5-(2-fluorofenil)-[1,2,4]oxadiazol -3-il]-benzoico. |
| RU2462247C2 (ru) | 2006-10-12 | 2012-09-27 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы дозирования перорально активного 1,2,4-оксадиазола для терапии, подавляющей нонсенс-мутацию |
| CN101714009A (zh) * | 2009-05-14 | 2010-05-26 | 翁印嵩 | 集成通用电话功能的计算机 |
| WO2012101292A1 (es) | 2011-01-25 | 2012-08-02 | Viviabiotech, S.L. | Derivados de 1,2,4-oxadiazol como fármacos moduladores del receptor para el péptido glp-1 |
| WO2014008257A2 (en) | 2012-07-02 | 2014-01-09 | Monsanto Technology Llc | Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles |
| CA3174516A1 (en) | 2014-03-06 | 2015-09-11 | Ptc Therapeutics, Inc. | Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid |
| CN105461650B (zh) * | 2014-09-12 | 2018-04-13 | 杭州普晒医药科技有限公司 | 一种噁二唑化合物的溶剂化物及其制备方法 |
| CN106316885B (zh) * | 2015-07-03 | 2019-02-12 | 普济生物科技（台州）有限公司 | 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法 |
| MX2018005361A (es) | 2015-10-30 | 2018-06-07 | Ptc Therapeutics Inc | Metodos para tratar epilepsia. |
| TW201808922A (zh) | 2016-06-20 | 2018-03-16 | 台灣神隆股份有限公司 | 製備阿塔魯仁及其中間體的方法 |
| US20220071965A1 (en) | 2018-12-20 | 2022-03-10 | Pfizer Inc. | Pharmaceutical Compositions and Methods Comprising A Combination of a Benzoxazole Transthyretin Stabilizer and an Additional Therapeutic Agent |
| WO2022112919A1 (en) | 2020-11-25 | 2022-06-02 | Pfizer Inc. | (aza)benzothiazolyl substituted pyrazole compounds |
| CN113045510B (zh) * | 2021-03-31 | 2022-05-27 | 北京大学生命科学华东产业研究院 | 一种阿塔鲁伦的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2801509A1 (de) * | 1978-01-12 | 1979-07-19 | Schering Ag | 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel |
| DE3905242A1 (de) * | 1989-02-21 | 1990-08-23 | Basf Ag | Verfahren zur herstellung von phenyloxdiazolylanilinen |
| NZ234760A (en) * | 1989-08-18 | 1991-09-25 | Sterling Drug Inc | Antiviral oxazole compounds and compositions |
| DE4425794A1 (de) * | 1994-07-21 | 1996-01-25 | Basf Ag | Nitrofarbstoffe |
| US6660753B2 (en) * | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| IL159086A0 (en) * | 2001-06-08 | 2004-05-12 | Cytovia Inc | 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same |
| MY151199A (en) * | 2001-11-02 | 2014-04-30 | Rigel Pharmaceuticals Inc | Substituted diphenyl heterocycles useful for treating hcv infection |
| WO2004014370A2 (en) * | 2002-08-09 | 2004-02-19 | Astrazeneca Ab | Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| GB0303503D0 (en) | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
| ES2926542T3 (es) * | 2003-04-11 | 2022-10-26 | Ptc Therapeutics Inc | Compuestos de ácido 1,2,4-oxadiazol benzoico y su uso para supresión de mutaciones finalizadoras y el tratamiento de enfermedades |
| US20050075375A1 (en) * | 2003-05-14 | 2005-04-07 | Anadys Pharmaceuticals, Inc. | Heterocyclic compounds for treating hepatitis C virus |
| CA2603402C (en) * | 2005-04-08 | 2017-10-31 | Ptc Therapeutics, Inc. | Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| RU2495030C2 (ru) * | 2006-09-08 | 2013-10-10 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы получения 1,2,4-оксадиазолбензойных кислот |
-
2007
- 2007-09-06 RU RU2009113019/04A patent/RU2495030C2/ru active
- 2007-09-06 WO PCT/US2007/019561 patent/WO2008030570A1/en active Application Filing
- 2007-09-06 CA CA2842625A patent/CA2842625C/en active Active
- 2007-09-06 ES ES07837899T patent/ES2404348T3/es active Active
- 2007-09-06 AU AU2007292915A patent/AU2007292915B2/en active Active
- 2007-09-06 KR KR1020097007202A patent/KR101466368B1/ko active IP Right Grant
- 2007-09-06 BR BRPI0716996A patent/BRPI0716996B8/pt active IP Right Grant
- 2007-09-06 UA UAA200903350A patent/UA99265C2/ru unknown
- 2007-09-06 MY MYPI20090941A patent/MY148598A/en unknown
- 2007-09-06 EP EP07837899A patent/EP2059513B1/en active Active
- 2007-09-06 NZ NZ575511A patent/NZ575511A/en unknown
- 2007-09-06 JP JP2009527430A patent/JP5955494B2/ja active Active
- 2007-09-06 MX MX2009002439A patent/MX2009002439A/es active IP Right Grant
- 2007-09-06 ZA ZA200901782A patent/ZA200901782B/xx unknown
- 2007-09-06 DK DK07837899.9T patent/DK2059513T3/da active
- 2007-09-06 NZ NZ598012A patent/NZ598012A/xx unknown
- 2007-09-06 PT PT78378999T patent/PT2059513E/pt unknown
- 2007-09-06 CN CN200780041169.XA patent/CN101535284B/zh active Active
- 2007-09-06 PL PL07837899T patent/PL2059513T3/pl unknown
- 2007-09-06 CA CA2662749A patent/CA2662749C/en active Active
- 2007-09-06 US US11/899,813 patent/US7678922B2/en active Active - Reinstated
- 2007-09-07 PE PE2011001405A patent/PE20120669A1/es active IP Right Grant
- 2007-09-07 CL CL200702606A patent/CL2007002606A1/es unknown
- 2007-09-07 TW TW096133607A patent/TWI482761B/zh active
- 2007-09-07 AR ARP070103975A patent/AR062715A1/es not_active Application Discontinuation
- 2007-09-07 PE PE2007001203A patent/PE20080771A1/es active IP Right Grant
-
2009
- 2009-03-05 IL IL197445A patent/IL197445A/en active IP Right Grant
- 2009-11-13 US US12/617,757 patent/US8367841B2/en active Active
-
2010
- 2010-03-01 HK HK10102172.4A patent/HK1134094A1/xx unknown
-
2014
- 2014-05-20 JP JP2014103966A patent/JP2014193896A/ja active Pending
-
2017
- 2017-01-27 AR ARP170100223A patent/AR107474A2/es unknown
-
2020
- 2020-05-12 AR ARP200101362A patent/AR118922A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR062715A1 (es) | Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico | |
| BRPI0415855A (pt) | processo para preparação de ésteres de ácido 2-dihalogenacil-3-amino-acrìlico e ésteres de ácido 3-dihalogeno-metil-pirazol-4-carboxìlico | |
| CL2014002252A1 (es) | Proceso para preparar un compuesto de formula (xiv) o un anhidrido de acido borico del mismo. | |
| AR043436A1 (es) | Tetrahidroisoquinolinas sustituidas para uso como moduladores 5-ht6 | |
| ATE451380T1 (de) | Verfahren zur herstellung von bisphosphonsäureverbindungen | |
| BR112014014148A2 (pt) | misturas de ácidos difosfínicos e dialquilfosfínicos, processo para produção das mesmas e uso das mesmas | |
| GT200800154A (es) | N-sulfonilacion selectiva de alcoholes 2-amino trifluoroalquilo sustituidos | |
| AR057909A1 (es) | Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. | |
| JP2009517412A5 (es) | ||
| WO2013042973A3 (ko) | Ｉ-선 포토레지스트 조성물 및 이를 이용한 미세패턴 형성 방법 | |
| EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
| JP2007045816A5 (ja) | カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法 | |
| BR112012005126A8 (pt) | Cristalização de 4'-epidaunorubicina x hcl | |
| EA200501530A1 (ru) | Новые соединения бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат | |
| DE60014088D1 (de) | Verfahren zur herstellung von (nitroxymethyl)phenylestern von salicylsäurederivaten | |
| PE20070526A1 (es) | Metodos para preparar derivados de acido glutamico | |
| CN100448866C (zh) | 具有光学活性的2-羟甲基-3-取代苯基丙酸化合物及其拆分方法 | |
| DE60330152D1 (de) | Verfahren zur herstellung von nitrooxyderivaten von naproxen | |
| ATE466834T1 (de) | Verfahren zur herstellung von aminoadamantanen | |
| FR2964978B1 (fr) | Nouveaux substrats fluorescents, procede d'obtention de ces produits et leur application | |
| AR074151A1 (es) | Un derivado de benzoilbencenoacetamida, proceso de preparacion del mismo, forma polimorfica b de dicho compuesto, proceso de obtencion de dicha forma polimorfica b y su uso | |
| BR112012012908A2 (pt) | processo de preparo de um derivado de combretastatina | |
| WO2009021957A3 (en) | Tricyclic heterocyclic compounds as gaba a modulators | |
| BR112019009804A2 (pt) | 4-((6-bromopiridin-3-il)óxi)benzonitri¬la e processos de preparação | |
| AR046130A1 (es) | Metodos para la preparacion del acido (2-(8,9)- dioxo.2,6- diaza- biciclo ( 5.2.0) - non-1(7) - en -2-il) etil) fosfonico y esteres del mismo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |